✦ LIBER ✦

Chemotherapy in epithelial ovarian cancer

✍ Scribed by Sandro Pignata; Lucia Cannella; Davide Leopardo; Carmela Pisano; Giovanni Salvatore Bruni; Gaetano Facchini

Book ID: 116335601
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 210 KB
Volume: 303
Category: Article
ISSN: 0304-3835
DOI: 10.1016/j.canlet.2011.01.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is there a role for second-line chemothe

Is there a role for second-line chemotherapy in epithelial ovarian cancer?

✍ Kevin B. Knonf 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Consolidation Intraperitoneal Chemothera

Consolidation Intraperitoneal Chemotherapy in Epithelial Ovarian Cancer Patients Following Negative Second-Look Laparotomy

✍ Hector M. Tarraza Jr.; Charles R. Boyce; W.Gary Smith; Michael A. Jones 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Consolidation intraperitoneal chemothera

Consolidation intraperitoneal chemotherapy in epithelial ovarian cancer patients following negative second-look laparotomy

✍ H.M. Tarraza Jr.; C.R. Boyce; W.G. Smith; M.A. Jones 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Impact of race and age on duration betwe

Impact of race and age on duration between surgery and chemotherapy in epithelial ovarian cancer

✍ E. Stevens; R. Rana; J. Jaffe; J. Blumberg; T. Pradhan; Y. Lee 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Intraperitoneal chemotherapy in epitheli

Intraperitoneal chemotherapy in epithelial ovarian cancer: Do we know the best way to do it?

✍ Muhammad Adnan Khattak; Hilary Laura Martin 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 178 KB

Serum soluble Fas levels and prediction

Serum soluble Fas levels and prediction of response to platinum-based chemotherapy in epithelial ovarian cancer

✍ Parvesh Chaudhry; Radhika Srinivasan; Firuza D Patel; Sarala Gopalan; Siddhartha 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 199 KB 👁 1 views

## Abstract Epithelial ovarian cancer (EOC) is treated mainly by platinum‐based combination chemotherapy. Chemotherapy induces apoptosis in which the Fas/Fas ligand pathway is important. Serum soluble Fas (sFas) is a biomarker of this pathway and functionally inhibits Fas‐/FasL‐mediated apoptosis.